↓ Skip to main content

Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma

Overview of attention for article published in BMC Cancer, August 2011
Altmetric Badge

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma
Published in
BMC Cancer, August 2011
DOI 10.1186/1471-2407-11-328
Pubmed ID
Authors

Barbara Peric, Ivana Zagar, Srdjan Novakovic, Janez Zgajnar, Marko Hocevar

Abstract

Increased level of serum S100B can serve as a marker of metastatic spread in patients with cutaneous melanoma (CM). In patients with elevated S100 B and/or clinical signs of disease progression PET-CT scan is a valuable tool for discovering metastases and planning treatment.The aims of this study were to determine whether regular measurements of serum S100B are a useful tool for discovering patients with CM metastases and to evaluate the diagnostic value of PET-CT during the follow-up.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 30%
Student > Bachelor 3 13%
Other 2 9%
Student > Doctoral Student 2 9%
Researcher 2 9%
Other 3 13%
Unknown 4 17%
Readers by discipline Count As %
Medicine and Dentistry 7 30%
Agricultural and Biological Sciences 3 13%
Immunology and Microbiology 1 4%
Psychology 1 4%
Unspecified 1 4%
Other 4 17%
Unknown 6 26%